Objective: To determine the pattern of excretion in urine of 5-L-oxoproline, as a measure of glycine status, during the ®rst six weeks of life in Jamaican infants. Design: Spot samples of urine were collected from term and preterm infants at birth and longitudinally to four weeks of age, or at six weeks of age. 5-L-oxoproline was isolated by column chromatography and hydrolysed to L-glutamic acid, which was measured enzymatically and the results expressed relative to creatinine excretion. Setting: Maternity wards and postnatal clinic of the University Hospital of the West Indies. Subjects: African-Caribbean infants, 19 term and 21 preterm, from birth to four weeks of age, and 79 term infants at six weeks of age. Results: There were no differences between term and preterm infants. Excretion of 5-L-oxoproline increased progressively from birth, 141 mmol/mmol creatinine, to 270 mmol/mmol creatinine at four weeks of age. At six weeks of age, excretion was signi®cantly greater than at birth or four weeks of age, 525 mmol/mmol creatinine. Compared with infants born in England, the excretion of 5-L-oxoproline was not different at birth, but was signi®cantly greater in Jamaican infants at six weeks of age. Conclusions: Glycine status, indicated by increased excretion of 5-L-oxoproline, is marginal in Jamaican infants at six weeks of age, and this possibly re¯ects a limitation in the endogenous biosynthesis of glycine due to a dietary limitation of folate or vitamin B-12.
Introduction
The urinary excretion of 5-L-oxoproline has been used as a marker for glycine status (Jackson, 1991) . In normal adults low levels of 5-L-oxoproline are found in urine . The levels increase when the amount of glycine available to metabolism is reduced following the ingestion of large doses of compounds which conjugate with glycine, such as sodium benzoate or paracetamol (Jackson et al, 1987; Pitt, 1990) , or on diets low in protein . During growth the demands for glycine increase and levels of urinary 5-L-oxoproline are higher in infancy (Jackson et al, 1997a) , and particularly high in children gaining weight rapidly during recovery from severe malnutrition . Excretion is also increased during pregnancy (Persaud et al, 1989; Jackson et al, 1997b) . In English women relatively high rates of excretion are found during early pregnancy with only a modest further increase as pregnancy progresses. This contrasts sharply with pregnant Jamaican women, where 5-L-oxoproline excretion rises progressively as pregnancy advances, so that by late pregnancy excretion is about four times that seen during pregnancy in English women (Jackson et al, 1997b) . Having found very large differences in the pattern of 5-L-oxoproline excretion during late pregnancy in women in England and Jamaica (Jackson et al, 1997b) , we were interested to know how the excretion of 5-Loxoproline compared in newborn infants.
Methods
The study was carried out in infants born at the University Hospital of the West Indies. Approval for the study was given by the ethical committee of the Hospital and mothers agreed to allow their infants to participate after the nature of the investigation had been explained to them. The length of pregnancy was calculated from the ®rst date of the last menstrual period and con®rmed upon examination by the attending obstetrician. Infants delivered before 37 completed weeks of pregnancy were identi®ed as pre-term. In 19 term infants and 21 pre-term infants a spot sample of urine was collected into a sterile urine bag, within 48 h of birth and then at weekly intervals from birth to four weeks of age. When the results for these infants were analysed there appeared to be a trend towards increased excretion with age, when compared with the infants in England (Jackson et al, 1997a) , see below. Therefore, single samples of urine were collected for infants at the time of their routine postnatal visit to the clinic at six weeks of age. There were a further 79 infants in this group, all of whom were delivered as singletons at birth and in 54 there was detailed information in the mother's medical notes of the size at birth and maternal haemoglobin during pregnancy. The length, weight and head circumference of each infant was measured at six weeks of age by the nursing staff. Not all data were available for each infant. All infants were of African-Caribbean descent. Infants with major congenital abnormalities, erythroblastosis and infants born to diabetic mothers were excluded from the study.
Samples of urine were preserved in 6N HCl, 250 mL, and stored frozen at 74 C. The 5-L-oxoproline and creatinine content of the urine were measured at a later date.
Biochemcial analyses
Urinary 5-L-oxoproline was measured by a modi®cation of the method of van der Werf et al (1974) . This approach ensures that 5-L-oxoproline is measured without any contamination from 5-D-oxoproline which may be present, either derived from the diet or produced by the colonic micro-¯ora (van der Werf et al, 1975) . 5-Oxoproline was isolated by short column ion-exchange chromatography, free from glutamate and other amino acids. The 5-Loxoproline in the eluate was hydrolysed in hot acid to glutamic acid (McPherson & Slater, 1959 ) and the resulting L-glutamic acid measured enzymatically with glutamate dehydrogenase (EC1.4.1.2.) (Lund, 1984) ; for details see Jackson et al (1996) . Creatinine in the urine was measured by the alkaline picrate method of Jaffe as described by Bonsnes & Taussky (1945) , after pretreatment of the urine with Lloyd's reagent to remove interfering chromogens.
Statistical analysis
For analysis the infants were divided into term and pre-term by gestational age. Groups were compared using Kruskal± Wallis non-parameteric analysis of variance with differences between groups being sought with the Wilcoxon Rank sum test, for paired and unpaired data. Associations between variables were sought using regression analysis. Data were analysed using SPSS 6.0 for Windows. A value for P of`0.05 on a two tailed test was taken as indicating a statistically signi®cant difference. Results are reported as the mean and the 95% con®dence interval (95% CI).
Results
There were 19 term and 21 pre-term infants from whom urine was collected at intervals from birth to four weeks of age, with similar numbers of females in each group. The gestational age, birth weight and length and pattern of feeding after the ®rst week of life is shown for the two groups in Table 1 ). The urinary excretion of 5-L-oxoproline, expressed as mmol/mmol creatinine, is shown in Table  2 . There were no differences in 5-L-oxoproline excretion between the term and pre-term infants at birth, week 1 or weeks 2±3. At four weeks the term infants excreted less 5-L-oxoproline than the pre-term infants, a statistically signi®cant difference, but the numbers were small. For both term and pre-term infants excretion within the ®rst 72 h of birth was signi®cantly less than at later ages. There was a trend towards an increase in excretion with each week of age for the group as a whole.
In 79 infants urine was collected at six weeks of age and in these the excretion of 5-L-oxoproline was 525 mmol/ mmol creatinine (95% CI, 438±612), approximately double the excretion in infants between 2±4 weeks, Table 2, a highly signi®cant statistical difference (P 0.000). In 54 of the infants at six weeks of age there were measurements of size at birth and at six weeks and information on the mother's haemoglobin during pregnancy. On simple bivariate comparisons, there was no correlation between 5-Loxoproline and any of these infant or maternal measures. However, when 5-L-oxoproline was the dependent variable in a backward multiple linear regression analysis, which included length of gestation, current length and head circumference at birth, there was a signi®cant relationship for 5-L-oxoproline with length of gestation and length of the infant at six weeks of age (overall R square 0.15; F 4.5; P 0.015). There was no difference in the excretion of 5-L-oxoproline between boys and girls, nor did the method of feeding, breast or formula, in¯uence the excretion of 5-L-oxoproline.
Infants aged six weeks in Jamaica excreted more than twice the 5-L-oxoproline in urine, when compared with English infants at six weeks of age, 194 mmol/mmol creatinine (95% CI, 163±225), measured in a previous study (Jackson et al, 1997a) , a highly statistically signi®cant difference. For both term and pre-term infants the pattern of excretion of 5-L-oxoproline differed between Jamaica and England, Figure 1 . For the Jamaican infants there was a progressive linear increase in the urinary excretion of 5-Loxoproline/creatinine with age (Spearman correlation coef®cient: term infants, P 0.000, r 0.53; pre-term infants, P 0.000, r 0.49). By week six, in the term infants, the excretion of 5-L-oxoproline in urine was about four times the excretion at birth. In some infants excretion reached very high levels, up to 1.7 mmol/mmol creatinine. Signi®cantly different from`72h. a P`0.05.
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Discussion
The urinary excretion of 5-L-oxoproline has been used as a marker for glycine status in infants born in Kingston Jamaica, either at term or before term. There was no discernible difference between the two groups and in both groups the rate of excretion at birth was relatively low compared with later ages. There was a progressive increase in the excretion of 5-L-oxoproline, with an approximate doubling from birth to four weeks of age. In the group of infants in whom 5-L-oxoproline was measured at six weeks of age, the excretion was nearly twice that measured at four weeks and about four times that measured at birth. In individual infants excretion reached very high levels (1.7 mmol/mmol creatinine). The excretion of 5-L-oxoproline at six weeks of age in Jamaican infants is the highest we have measured for any group. Malnourished children in Jamaica, gaining weight rapidly on an energy dense formula feed excrete 172 mmol 5-L-oxoproline/mmol creatinine on average , and during late pregnancy Jamaican women excrete 131 mmol 5-L-oxoproline/mmol creatinine (Jackson et al, 1997b) . There are four main reasons why the excretion of 5-Loxoproline in urine might change with age, maturation of renal function, the diet of either the mother or the infant, development of a speci®c colonic micro-¯ora, metabolic constraint on the formation of glutathione with an alternative pathway of metabolism for g-glutamylcysteine.
Amino aciduria is normally seen in newborn infants, but tends to decline as renal function matures with age. The opposite pattern was seen with 5-L-oxoproline with excretion increasing with age, making renal immaturity an unlikely reason for the changes observed. The developing colonic micro-¯ora varies amongst infants fed either human milk or an infant formula. However, as there was no difference in the excretion of 5-L-oxoproline between infants who were breast-fed or those taking an infant formula it seems unlikely that the pattern of organisms in the colon could have exerted a substantial effect. Under exceptional circumstances high levels of 5-L-oxoproline in the urine have been associated with a particular formula, attributed to contamination of the formula with 5-D-oxoproline (Oberholzer et al, 1975) . In all situations where either a dietary source or the activity of the colonic bacteria have been imputed to explain higher levels of excretion of 5-oxoproline, the increase has been identi®ed as an increase in 5-D-oxoproline, not 5-L-oxoproline as measured in the present study (van der Werf et al, 1975; Oberholzer et al, 1975) .
We have associated a depletion of the metabolic pool of glycine with increased 5-L-oxoprolinuria in adults (Jackson et al, 1987; Jackson et al, 1996) , and in infants gaining weight rapidly during recovery from severe malnutrition . On this basis we have used the excretion of 5-L-oxoproline as an index of the relative availability of glycine for metabolism, with increased excretion indicating a constraint on the endogenous biosynthesis of glycine relative to the satisfaction of the demands for metabolism (Jackson, 1991) . This would only apply when the availability of glycine is limiting for glutathione formation. It is widely appreciated that the glutathione status of the body is sensitive to the dietary intake of cysteine, with diurnal changes in blood glutathione concentration related to the dietary intake of cysteine (Leaf & Neuberger, 1947 ). An adequate intake of cysteine and satisfactory cysteine status is necessary for an increase in 5-L-oxoproline excretion due to a constraint on the availability of glycine. Therefore, the increasing excretion of 5-L-oxoproline with age could be the consequence of a progressive improvement in cysteine status exposing a more severe constraint in the availability of glycine.
The results of the present study differ from those obtained in infants in England in two respects. Firstly, in England there was a consistent difference between term and pre-term infants (Jackson et al, 1997a) . That this was not seen in Jamaica might simply be due to the fact that in Jamaica there was only a small group of pre-term infants, but a more likely explanation is that the pre-term infants were still hospitalised, ill and not thriving. Secondly, in England the excretion of 5-L-oxoproline increased to a maximum level at about two weeks of age, with no further increase (Jackson et al, 1997a) . By contrast, in Jamaica, excretion increased progressively up to the latest age at which measurements were made, six weeks. This demonstration of an apparent metabolic difference between infants in the two locations is similar to the differences we have noted in the excretion of 5-L-oxoproline as pregnancy advances (Jackson et al, 1997b) . In both situations as the metabolic demands increase with the need for growth, there is a more marked increase in 5-Loxoproline excretion in Jamaica than in England. The difference could be environmental or genetic. We have no information to identify the differences as having a genetic basis.
If a limitation in the availability of glycine to satisfy metabolic needs were the basis of the difference between the two groups, either a constraint on the ability to form Urinary 5-L-oxoproline in Jamaican infants C Persaud et al glycine, or a difference in demand might contribute to the relative imbalance. There are two pathways through which glycine is thought to be formed in the body, the glycine cleavage system and peroxisomal aminotransferase, and neither has been adequately characterized quantitatively (Jackson, 1991) . Both pathways are dependent upon B vitamins as co-factors. Folates and vitamin B-12 in particular, are associated with the interchange of serine and glycine. The dietary availability of folate is potentially marginal in Jamaica, and there is limited evidence to suggest that there may be increased degradation of folates with exposure to ultraviolet light (Jackson et al 1997b) . Diets in Jamaica might be lower in animal protein, and would therefore be more likely to be limiting in vitamin B-12. The rate and pattern of growth of infants up to three months of age is broadly similar in the two locations, but if anything the demand for linear growth may be greater in Jamaica. In both the present study, and the earlier study in English infants (Jackson et al, 1997a) , 5-L-oxoproline excretion was higher in infants born at an earlier gestational age, suggesting that relative immaturity of the enzyme systems, or poor acquisition of prenatal stores of vitamin B-12 and folate might be a contributing factor. In the present study length at six weeks of age was associated with 5-L-oxoproline excretion, suggesting that shorter infants have higher rates of excretion and raising the possibility that the availability of glycine might be limiting for the deposition of collagen.
